These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2986321)

  • 1. [Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Apr; 161(4):239-43. PubMed ID: 2986321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Jan; 161(1):23-9. PubMed ID: 2982221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].
    Makoski HB; Scherer E; Magnus L; Verbeek W
    Strahlentherapie; 1978 Mar; 154(3):169-73. PubMed ID: 635942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].
    Müller RP; Schnepper E; Peters PE; Fladerer W
    Strahlentherapie; 1980 Aug; 156(8):538-41. PubMed ID: 7414647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].
    Winkel K; Becker J; Jahns E; Scheurlen H; Herzfeld U
    Strahlentherapie; 1967 Aug; 133(4):481-98. PubMed ID: 4298455
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution pattern of radioactive labelled lipiodol-UF following intralymphatic application for therapy.
    Weissleder H; Pfannenstiel P; Peters PE
    Lymphology; 1976 Sep; 9(3):122-6. PubMed ID: 187879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endolymphatic radiotherapy in malignant lymphomas. A clinical evaluation of 285 patients.
    Bonadonna G; Chiappa S; Musumeci R; Uslenghi C
    Cancer; 1968 Oct; 22(4):885-98. PubMed ID: 4378035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitality evaluation of malignant melanoma metastases following endolymphatic radionuclide therapy using the Falck-Hillarp method].
    Paul E; Illig L; Möller W
    Hautarzt; 1975 Jun; 26(6):317-20. PubMed ID: 1165195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
    Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
    Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intralymphatic treatment of lymph-node metastases with Lipiodol labeled with I-131, with special reference to malignant melanoma].
    Edwards JM
    Minerva Med; 1967 Dec; 58(99):4512-3. PubMed ID: 4295505
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental studies of intralymphatic administration of radiotherapy with particular emphasis on lymphatic dynamics and lymph node response to lymphography.
    Koehler PR; Potchen EJ; Cole WR; Studer R
    Radiology; 1968 Mar; 90(3):495-501. PubMed ID: 4296003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endolymphatic radionuclide therapy. Historical development and present status].
    Makoski HB; Magnus L; Scherer E; Stauch GW; Strötges MW
    Dtsch Med Wochenschr; 1973 Nov; 98(46):2207-13. PubMed ID: 4593334
    [No Abstract]   [Full Text] [Related]  

  • 14. [Examination technic and monitoring of patients in endolymphatic radionuclide therapy].
    Peters PE
    Med Welt; 1974 Jun; 25(23):1031-5. PubMed ID: 4409524
    [No Abstract]   [Full Text] [Related]  

  • 15. Iotasul, a water-soluble (non-oily) contrast medium for direct and indirect lymphography: radiological and morphological investigations in dogs.
    Wenzel-Hora BI; Kalbas B; Siefert HM; Arndt JO; Schlösser HW; Huth F
    Lymphology; 1981 Sep; 14(3):101-12. PubMed ID: 7289668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
    Richter G; Heidenbluth I; Heidelbach U
    Dermatol Monatsschr; 1982 Dec; 168(12):797-806. PubMed ID: 7169101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histological changes of the lymph nodes during radiant lymphography].
    Accinelli G; Ragni N; Rugiati S
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1463-72. PubMed ID: 4314290
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological and clinical problems in radiant lymphography in gynecological neoplasms].
    Ragni N; Cavalli D; Accinelli G
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1473-83. PubMed ID: 4314291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dose distribution in healthy and metastatic lymph nodes after endolymphatic radionuclide therapy. II. Rabbit experiments using 32phosphorus-tri-n-octyl-phosphate and 125 iodine-trioleate in lipidol UF].
    Magnus L
    Strahlentherapie; 1973 Jun; 145(6):631-43. PubMed ID: 4375316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiation-dosimetry studies after endolymphatic radionuclide therapy].
    Pfannenstiel P
    Med Welt; 1974 Jun; 25(23):1038-42. PubMed ID: 4369658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.